Jose A. Caminero, University General Hospital of Gran Canaria, Las Palmas, Spain and MDR-TB Unit Coordinator, The UNION, Paris, France – (Clinical practice, representative from gGLC).
Gavin Churchyard, Chief Executive Officer, Aurum Institute for Health Research, Johannesburg, South Africa – (STAG-TB member, clinical practice, TB, TB/HIV, research, drug and vaccine development).
Anna Marie Celina Garfin, Department of Health – National Center for Disease Prevention and Control, Philippines – (Programme management, end-user).
Giovanni Battista Migliori, Director, WHO Collaborating Centre for TB and Lung Diseases Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy – (STAG-TB member, pulmonologist/MDR-/XDR-TB expert and TB technical adviser).
Ashok Kumar, Deputy Director General, Head Central TB Division & Project Director RNTCP, Directorate General Of Health Services, Ministry of Health and Family Welfare, New Delhi, India – (Programme management, end-user).
Helen McIlleron, Division of Clinical Pharmacology, Department of Medicine, University of Cape Town – (Clinical pharmacologist).
Richard Menzies, Director Respiratory Division, MUHC and McGill University, Montreal, Canada – (Epidemiologic and clinical research in TB).
Rohit Sarin, Director, LRS Institute of Tuberculosis and Respiratory Diseases, New Delhi, India and Chairman – (Clinical consultant in TB and Respiratory Diseases, member of rGLC SEAR, end-user).
Alena Skrahina, Scientific Director, Republican Research and Practical Centre for Pulmonology and TB, Minsk, Belarus – (Clinical management and research, TB, M/XDR-TB, HIV/TB, end-user).
Maarten van Cleeff, KNCV Tuberculosis Foundation, The Hague, The Netherlands – (TB, TB/HIV, poverty and ethics, diagnosis, health system strengthening, operational research, monitoring and programme evaluation).
